Page last updated: 2024-11-07

penicillamine and Chronic Fatigue and Immune Dysfunction Syndrome

penicillamine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, M1
Nishiura, T1
Yoshimura, M1
Horikawa, Y1
Yoshida, H1
Okajima, Y1
Matsumura, I1
Ishikawa, J1
Nakao, H1
Tomiyama, Y1
Kanayama, Y1
Kanakura, Y1
Matsuzawa, Y1

Other Studies

1 other study available for penicillamine and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome.
    European journal of clinical investigation, 1998, Volume: 28, Issue:11

    Topics: Adjuvants, Immunologic; Adult; Arginine; Base Sequence; Case-Control Studies; DNA Primers; Enzyme In

1998